Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Gross Margin (2016 - 2025)

Apyx Medical (APYX) has disclosed Gross Margin for 15 consecutive years, with 62.61% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 42.0% year-over-year to 62.61%, compared with a TTM value of 62.53% through Dec 2025, up 149.0%, and an annual FY2025 reading of 62.53%, up 149.0% over the prior year.
  • Gross Margin was 62.61% for Q4 2025 at Apyx Medical, down from 64.43% in the prior quarter.
  • Across five years, Gross Margin topped out at 72.22% in Q4 2021 and bottomed at 58.07% in Q1 2024.
  • Average Gross Margin over 5 years is 64.39%, with a median of 63.8% recorded in 2022.
  • The sharpest move saw Gross Margin surged 1838bps in 2021, then crashed -688bps in 2022.
  • Year by year, Gross Margin stood at 72.22% in 2021, then dropped by -10bps to 65.35% in 2022, then decreased by -7bps to 60.9% in 2023, then rose by 3bps to 63.03% in 2024, then decreased by -1bps to 62.61% in 2025.
  • Business Quant data shows Gross Margin for APYX at 62.61% in Q4 2025, 64.43% in Q3 2025, and 62.28% in Q2 2025.